Headline: Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial
Location: Boston, MA, US
Post Date: Nov 25, 2021 7:30 PM
TAG ID: pznews294460
DocID: 202111268400976-en.xml
Word Count: approx. 1017 words
 
Cloverâs COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial
 
Please login to download this Story